IntroductionCrimean-Congo hemorrhagic fever (CCHF) is a severe and fatal disease that is transmitted by ticks and often presents with bleeding symptoms in humans. The causative agent is the CCHF virus, an RNA virus of the Nairovirus lineage belonging to the family Bünyaviridae. It was first described in the Crimea in 1944, when it affected more than 200 people [1]. CCHF has been reported in more than 30 countries in Eastern Europe, Africa, the Balkans, Russia, Central Asian Republic, and the Middle East. The spread of the virus over a wide geographic area would result in a severe disease leading to high mortality in humans. The absence of a specific effective treatment and vaccine against the virus, in addition to its potential to be used as a bioterror agent or biological weapon, have made it an important human pathogen and a major public health problem worldwide [2]. In Turkey, CCHF is mainly seen in Erzurum,